Altered neurovascular coupling (NVC), the process that matches brain activity with the blood flow needed to support it, is associated with poorer cognitive function and greater disability in people with multiple sclerosis (MS), a study found. The most consistent finding was an abnormal balance between blood flow and spontaneous…
Discussion
The U.S. Food and Drug Administration (FDA) has agreed to review an application from Roche seeking approval of its BTK inhibitor fenebrutinib as a treatment for relapsing forms of both multiple sclerosis (MS) and primary progressive MS (PPMS). Further, the FDA granted the application priority review, under…
Discussion
An estimated 3.1 million people worldwide are now living with multiple sclerosis (MS), up from about 2.8 million in 2020, according to the latest update of the Multiple Sclerosis International Federation’s Atlas of MS. The new estimate means that global MS prevalence — the number of people living…
Discussion
With multiple sclerosis (MS), pain can sometimes be obvious, and sometimes it is something I carry quietly while I go about my day. From the outside, I might look fine. I can have a conversation, answer emails, laugh with someone, or get through everything I need to do, but…
Discussion
An experimental therapy called kamuvudine-9 (K-9) reversed established paralysis and vision loss in a mouse model of multiple sclerosis (MS), offering hope for treatments that can restore lost function rather than just prevent future damage. “Most MS therapies are aimed at preventing the next attack. What’s remarkable is…
Get regular updates to your inbox.
